Certolizumab pegol for induction of remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet
twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 111 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 news story.

Cochrane Review Confirms Efficacy of Certolizumab in Crohn's

Medscape, 02 Oct 2019

NEW YORK (Reuters Health) - Certolizumab pegol (CZP) is more effective than placebo for inducing remission in Crohn's disease (CD…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.